Prescription drug · ANDA
Methenamine hippurate NDC 72578-175
Methenamine hippurate 1 g/1 · Tablet · Oral · Viona Pharmaceuticals Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72578-175-01 | 7257801750172578017501 | 100 TABLET in 1 BOTTLE (72578-175-01)Marketed from Mar 12, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methenamine hippurate
- Generic name (nonproprietary)
- methenamine hippurate
- Active ingredients
- Methenamine hippurate — 1 g/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Viona Pharmaceuticals IncNDC labeler code 72578
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 219661
- Marketing start
- Listing expires
- Identifiers
- Product ID 72578-175_d3ad1ad7-1d50-420e-9e4e-ba9283325925SPL ID d3ad1ad7-1d50-420e-9e4e-ba9283325925SPL set ID 759b3725-0934-4974-a3ac-59a20aee81c6RxCUI 992150UNII M329791L57
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472578017501followed by a unit qualifier and the quantityPackage 72578-0175-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS Methenamine hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents. To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate tablets and other antibacterial drugs, methenamine hippurate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in sele…
Excerpt only. Read the full label for complete information.
About NDC 72578-175
- What is NDC 72578-175?
- 72578-175 is the product NDC for Methenamine hippurate, Methenamine hippurate 1 g/1 tablet, listed with the FDA by Viona Pharmaceuticals Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methenamine hippurate.
- What is the active ingredient?
- Methenamine hippurate.
- Who is the labeler?
- Viona Pharmaceuticals Inc, NDC labeler code 72578. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methenamine hippurate?
- 11 other product NDCs are listed under this name. See all Methenamine hippurate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methenamine hippurate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | ANI Pharmaceuticals, Inc. | 70954-959 | 70954-0959-10 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | NorthStar Rx LLC | 72603-816 | 72603-0816-01 |
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Zydus Lifesciences Limited | 70771-1919 | 70771-1919-01 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-797 | 59746-0797-0159746-0797-65 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | American Health Packaging | 60687-694 | 60687-0694-21 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-142 | 50742-0142-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | AvPAK | 50268-549 | 50268-0549-15 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-880 | 51407-0880-01 |
| Methenamine Hippurate | Methenamine hippurate 1000 mg/1 | TabletOral | Micro Labs Limited | 42571-332 | 42571-0332-0142571-0332-23 |
| Methenamine Hippurate | Methenamine hippurate 1 g/1 | TabletOral | Aurobindo Pharma Limited | 65862-782 | 65862-0782-01 |
Other NDCs under ANDA 219661
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methenamine hippurate | Methenamine hippurate 1 g/1 | TabletOral | Zydus Lifesciences Limited | 70771-1919 |